On Oct 11, 180 Life Sciences Received Notice From Nasdaq, Co Not In Compliance With Shareholder Approval Requirements Set Forth In Listing Rule 5635(D)
Portfolio Pulse from Benzinga Newsdesk
180 Life Sciences has received a notice from Nasdaq stating that the company is not in compliance with the shareholder approval requirements as per Listing Rule 5635(D), according to an SEC filing.
October 13, 2023 | 9:08 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
180 Life Sciences, listed as ATNF, has been notified by Nasdaq of its non-compliance with shareholder approval requirements. This could potentially lead to a negative impact on the company's stock price.
Non-compliance with Nasdaq's shareholder approval requirements could lead to potential penalties or even delisting, which would negatively impact the company's stock price. Investors may lose confidence in the company, leading to a sell-off.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100